JPS60214864A - Nutritious supplementary food - Google Patents

Nutritious supplementary food

Info

Publication number
JPS60214864A
JPS60214864A JP59070529A JP7052984A JPS60214864A JP S60214864 A JPS60214864 A JP S60214864A JP 59070529 A JP59070529 A JP 59070529A JP 7052984 A JP7052984 A JP 7052984A JP S60214864 A JPS60214864 A JP S60214864A
Authority
JP
Japan
Prior art keywords
tocopherol
soybean lecithin
oil
delta
mixed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP59070529A
Other languages
Japanese (ja)
Inventor
Osamu Fukuoka
福岡 脩
Akiichi Oota
太田 明一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hohnen Oil Co Ltd
Original Assignee
Hohnen Oil Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hohnen Oil Co Ltd filed Critical Hohnen Oil Co Ltd
Priority to JP59070529A priority Critical patent/JPS60214864A/en
Publication of JPS60214864A publication Critical patent/JPS60214864A/en
Pending legal-status Critical Current

Links

Landscapes

  • Edible Oils And Fats (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Seeds, Soups, And Other Foods (AREA)

Abstract

PURPOSE:To titled novel food, obtained by sealing a mixed liquid material prepared by dissolving delta-tocopherol, etc. and soybean lecithin in a liquid vegetable oil in a gelatin capsule, and having improved ability to reduce blood cholesterol. CONSTITUTION:A nutritious supplementary food obtained by sealing a mixed liquid material prepared by dissolving delta-tocopherol or a mixed tocopherol at composition ratio of the delta-tocopherol increased to >=50% and soybean lecithin preferably at 10pts.wt.: 1-100pts.wt. ratio between the former and the latter in a liquid vegetable oil, e.g. corn oil, in a gelatin capsule.

Description

【発明の詳細な説明】 本発明はδ−トコフェロール、大豆レシチンを有効成分
とし、降コレステロール作用を有する新規な栄養補助食
品に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel nutritional supplement containing δ-tocopherol and soybean lecithin as active ingredients and having a cholesterol-lowering effect.

近年、■豊かな食生活がもたらす栄養バランスの偏抄、
■嗜好優先の食生活がもたらす偏食、過剰摂取、■運動
、休息、栄養の鍵康保持バランスのくずれによる栄養損
失、■高齢化社会に対応し得る補助栄養の必然性1等の
要素を背景として栄養補助食品の需要が急激に増加して
お9、特に成人病は食生活の改善によって予防せんとす
る思想が強いため栄養補助食品が好まれて食されている
In recent years, there has been an increase in the nutritional balance brought about by a rich diet,
■Unbalanced eating and excessive intake caused by a diet that prioritizes preferences; ■Nutritional loss due to loss of balance in maintaining health, which is the key to exercise, rest, and nutrition; ■The necessity of supplementary nutrition to cope with an aging society. The demand for supplementary foods is rapidly increasing9, and nutritional supplements are being preferred, especially since there is a strong belief that adult diseases can be prevented by improving dietary habits.

本発明はこのような食生活上のニーズから導かれyTh
4のであり、δ−トコフェロールと大豆レシチンの相乗
効果によって血中コレステロール(D低下能が著るしく
優れた新規な栄養補助食品を提供せんとするものである
The present invention was derived from such dietary needs.
4, and aims to provide a novel nutritional supplement that has a remarkable ability to lower blood cholesterol (D) through the synergistic effect of δ-tocopherol and soybean lecithin.

本発明者らは先に、δ−トコフェロールがα〜トコフェ
ロールに比ベビタミンE活性が1/I DOでめるにも
かかわらず、血中コレステルールの低下作用が極端に優
れているという新知見を得、このδ−トコフェロールを
単離して使用するかあるいはδ−トコフェロールの組成
比を50%以上に高めた混合トコフェロール(トコフェ
ロール同族体混合物、スなわち、α−1β−1γ−1δ
−トコフェロールの混合物)を使用することにより、血
中コレステロールの低下効果を著るしく向上し得ること
を見出し、特許出願した。 − 不発aAFie(Da−)コアエローkK大豆レシチン
を併用すること罠より、そあ相乗効果によって血中コレ
ステ日−ルの低下効果をさらに一段と向上したものであ
る。
The present inventors previously discovered a new finding that δ-tocopherol has an extremely superior blood cholesterol-lowering effect even though its vitamin E activity is 1/I DO compared to α-tocopherol. This δ-tocopherol can be isolated and used, or mixed tocopherols (tocopherol homolog mixtures, i.e. α-1β-1γ-1δ) in which the composition ratio of δ-tocopherol is increased to 50% or more are used.
We have found that the effect of lowering blood cholesterol can be significantly improved by using a mixture of tocopherols (a mixture of tocopherols), and have applied for a patent. - Unexploited aAFie (Da-) Core Yellow KK Soybean lecithin has a synergistic effect that further improves the effect of lowering blood cholesterol levels.

すなわち、本発明はδ−トコフェロールまたはδ−) 
コア zロールの組成比を50tX以上に高めた混合ト
コ7ヱロールと大豆レシチンを液状植物油に・!#して
なる混合液状物をゼラチンのカプセル内に刺入し走栄養
補助食品である。
That is, the present invention provides δ-tocopherol or δ-)
A mixture of Toko7erol and soybean lecithin with a higher composition ratio of Core Z-roll than 50tX in liquid vegetable oil! This is a nutritional supplement made by inserting a liquid mixture of # into a gelatin capsule.

本発明における栴1の特徴は、使用するトコフェロール
が従来一般に用いられているα−トコフェロールあるい
けα−トコフェロールを主体とする混合トコ7エa−ル
ではなく、単離したδ−トコフェロールまたはδ−トコ
フェロールの組成比が50%以上の混合トコフェロール
を用いる点でありとのδ−トコフェロールの使用によ抄
血中フレステロールの低下効果を著るしく向上し得た点
である。
The feature of Sei 1 in the present invention is that the tocopherol used is not the conventionally commonly used α-tocopherol or mixed tocopherol mainly composed of α-tocopherol, but isolated δ-tocopherol or δ-tocopherol. The use of mixed tocopherols having a tocopherol composition ratio of 50% or more and the use of δ-tocopherol significantly improved the effect of lowering fresterol in blood samples.

本発明において使用するδ−トコフェロールは、例えば
大豆油、小麦胚芽油、ゴマ油、米ぬか油等の植物油に含
まれていることが知られており、製造に際しては公知の
製造方法例えば上記植物油の脱臭工程で得られる脱臭溜
出物(所謂脱臭スカム)を分子蒸留し奪秒、あるいは有
機溶媒に溶解してイオン交換樹脂や吸着クロマトグラフ
ィー等に吸着させた後さらに有機溶媒を使用してトコフ
ェロール類の各フラクションを分別する方法、おるいは
合成法等によって得ることができるが、その製造法や起
#は特に限定されない。
The δ-tocopherol used in the present invention is known to be contained in vegetable oils such as soybean oil, wheat germ oil, sesame oil, and rice bran oil, and can be produced using known manufacturing methods such as the above-mentioned deodorizing process of the vegetable oil. The deodorized distillate (so-called deodorized scum) obtained is subjected to molecular distillation and deodorization, or it is dissolved in an organic solvent and adsorbed on an ion exchange resin or adsorption chromatography, and then an organic solvent is used to extract each of the tocopherols. It can be obtained by a method of fractionating fractions, a synthesis method, etc., but its production method and origin are not particularly limited.

なお、単離したδ−トコフェロールは、酸化防止剤など
の用途′t−目的として既に市販されているので、この
市販品を使用することも可能である。
Note that the isolated δ-tocopherol is already commercially available for uses such as antioxidants, so it is also possible to use this commercially available product.

また、単離したδ−トコフェロールを混合トコフェロー
ルに添加したり、混合トコフェロール中のδ−トコフェ
ロ〜ルを選択的に濃縮すること等によってδ−トコフェ
ロールの組成比を50%以上に高めた混合トコフェロー
ルを使用しても本発明の効果は得られる。
In addition, mixed tocopherols with the composition ratio of δ-tocopherol increased to 50% or more can be obtained by adding isolated δ-tocopherol to mixed tocopherols or selectively concentrating δ-tocopherol in mixed tocopherols. Even if it is used, the effects of the present invention can be obtained.

本発明における第2の特徴は、とのδ−トコフェ四−ル
と大豆レシチンを併用した点であり、この併用による相
乗効果にょ゛りて血中コレステロールの低下効果をさら
に一段と向上し得た点である。
The second feature of the present invention is that δ-tocopheryl and soybean lecithin are used together, and the synergistic effect of this combination further improves the blood cholesterol lowering effect. It is.

不発8Aにおいて使用する大豆レシチンは通常、大豆油
の脱ガム工程で剛生するガム質を脱水、乾燥して得られ
る大豆油を含んだ大豆リン脂質<lvrm太豆レシチン
)が適当であるが、アセト/、アルコール等により精製
または濃縮されたレシチンを用いてもよく、また、り7
アリン含量の少ないもしくはケファリン含量のなi分別
レシチンを使用することもできる。
The soybean lecithin used in Fudashi 8A is usually soybean phospholipid containing soybean oil (lvrm soybean lecithin) obtained by dehydrating and drying the gum that hardens during the soybean oil degumming process. /, lecithin purified or concentrated with alcohol etc. may be used;
It is also possible to use fractionated lecithins with a low arine content or a cephalin content.

δ−トコフェロールと大豆レシチンとの配合割合Fi#
KII4定されるものではないが1本発明の効果をより
有効に発揮させるためにはδ−トコフェロール10重量
部に対して大豆レシチン1−100重量部程度配合する
仁とが好ましい。
Blending ratio of δ-tocopherol and soybean lecithin Fi#
KII4 Although not specified, in order to more effectively exhibit the effects of the present invention, it is preferable to mix about 1 to 100 parts by weight of soybean lecithin to 10 parts by weight of δ-tocopherol.

δ−トコフェμm化またはδ−トコフェロールの組成比
が5ON以上の混合トコフェロールおよび大豆レシチン
を溶解するための液状植物油としては、小麦胚芽油、米
油、コーン油等の胚芽油、大豆油、菜種油、綿実油、ひ
まわり油、サフラワー油、落花生油等の種実油、等、通
常食用に供せられている総ての液状油が使用でき、これ
らの液状植物油は含l1III81子より公知の方法で
採取、N製したものな用いる。
Liquid vegetable oils for dissolving soybean lecithin and mixed tocopherols having a composition ratio of 5ON or more of δ-tocopherol or δ-tocopherol include germ oils such as wheat germ oil, rice oil, and corn oil, soybean oil, rapeseed oil, All liquid oils commonly used for human consumption can be used, such as cottonseed oil, sunflower oil, safflower oil, seed oil such as peanut oil, etc. These liquid vegetable oils can be extracted from 11III81 seeds by known methods. Use one made of N.

特に胚芽油は、トコフェロール類、リノール酸等奢多量
に含み、降コレステロール作用を有するので本発明の栄
養補助食品として好適である。
In particular, germ oil is suitable as a nutritional supplement of the present invention because it contains a large amount of tocopherols, linoleic acid, etc. and has a cholesterol-lowering effect.

δ〜トスフェロールt+1dJ−)コフヱロールの組成
比が50%以上の混合トコフェロールおよび大豆レシチ
ンを液状植物油に溶解してなる混合液状物は、次いで、
常法に従ってゼラチンのカブ竜ル内に封入する。
δ~tospherol t+1dJ-) A mixed liquid product obtained by dissolving mixed tocopherols and soybean lecithin in which the composition ratio of cofurol is 50% or more in a liquid vegetable oil is as follows:
Seal it in a gelatin tube according to the usual method.

この刺入方法の一例としては、混合液状物をゼラチン、
グリセリン、および氷を溶融後射出成型したゼラチンカ
プセルに所定量注入し、その後、注入口を加熱密刺して
本発明の栄養補助食品を製造する。
One example of this method is to insert a liquid mixture into gelatin,
After melting glycerin and ice, a predetermined amount is injected into an injection-molded gelatin capsule, and then the injection port is heated and tightly pierced to produce the nutritional supplement of the present invention.

セラチンカフセルの形状は球形、ラフビーポール形勢任
意である。
The shape of the Seratin cuff cell can be spherical or rough pole.

ζγよう托して得られた本発明の栄養補助食品は、血中
コレステロールの低下効果が署るしく優れえものであり
、近年増加の一途をたどりて匹る動脈硬化症、高血圧、
血栓、狭心症、脳卒中、心筋梗塞等のごとき成人病の予
防に極めて有効と言えるものである。
The nutritional supplement of the present invention obtained by preparing ζγ has a remarkable effect on lowering blood cholesterol, and has been found to be effective in reducing arteriosclerosis, high blood pressure, and other diseases that have been increasing in recent years.
It can be said to be extremely effective in preventing adult diseases such as blood clots, angina pectoris, stroke, myocardial infarction, etc.

次に、本発明の効果をさらに明確にするために実験例を
あげる。
Next, an experimental example will be given to further clarify the effects of the present invention.

実験例 α−トコフェロール、−一トプフェ四−ルおよび大豆レ
シチン投与によるラットの血漿コレステロールおよび中
性脂肪の低下作用確認試験。
Experimental Example A test to confirm the effect of lowering plasma cholesterol and triglyceride in rats by administration of α-tocopherol, -tophenyl and soybean lecithin.

4週令8D系雄ラットを1群6頭づつの3群に分けて用
V%た。
4-week-old 8D male rats were divided into 3 groups of 6 rats per group and tested for V%.

飼料ハコレスチロール0.5%、コール酸ナトリウム0
.25Nを負荷した高コレステロール崩症を発生し易i
ものを対照とし、これにそれぞれ、■d〜α−ト=ズ7
エロールo、5%、(ld−δ−トコフェロ−xo、5
N、■大豆レシチン0.5%および■d−δ−トコフェ
ロール0.25%ト大豆レシチン0.25Xを併用添加
したものの5mとした。
Feed hacholestyrol 0.5%, sodium cholate 0
.. Easily develops hypercholesterolemia when loaded with 25N
d~α-t=z7
Erol o, 5%, (ld-δ-tocophero-xo, 5
N, (1) Soybean lecithin 0.5% and (2) d-δ-tocopherol 0.25% soybean lecithin 0.25X were added together to make 5 m.

これらの飼料をラットに対して飼料摂取量が1B1填f
iり15〜16fとなるように与えつつ2週間飼育した
稜に、各群のラットの尾部よ抄採血し、血漿コレステロ
ールおよび中性脂肪としてトリグリ七リドを酵素法によ
りて測定した。
These feeds were given to rats with a feed intake of 1B1f.
Rats in each group were reared for two weeks while being fed an i.i.

その結果を次表に示す。The results are shown in the table below.

(?J’ ) 表中の動脈硬化指数は HD Lコレステロール で表わされる。(?J’) The arteriosclerosis index in the table is HD L cholesterol It is expressed as

上表の結果かられかるように、低い方が好ましいとされ
る血漿紺コレステロールは、δ−トコフェロールと大豆
レシチン併用nが最も上列が抑制噛れていた 、11!+ 當、善玉コレステロールといわれ数値が高
い方がよいとされているHDLコレステロールは、α−
トコフェロール群、δ−トコフェロール群およびδ−ト
コフェロールと大豆レシチン併用群の3群間に有意差は
なかったが、動脈硬化指数についてはδ−トコ7エa−
ルと大豆レシチン併用群が最も低い値を示し、その相乗
効果が認められた。
As can be seen from the results in the table above, plasma dark cholesterol, which is considered to be lower, was the most suppressed in the upper row by the combination of δ-tocopherol and soy lecithin, 11! + HDL cholesterol, which is said to be good cholesterol and the higher the value is, is α-
There was no significant difference between the three groups: tocopherol group, δ-tocopherol group, and δ-tocopherol and soy lecithin combination group, but regarding the arteriosclerosis index, δ-tocopherol a-
The combination group with lecithin and soybean lecithin showed the lowest value, indicating a synergistic effect.

tた、数値が低い方がよいとされるトリグリセライドに
ついてもδ−トコフェロールと大豆レシチン併用群が有
意に低下していることが認められた。
Furthermore, triglycerides, which are considered to have lower values, were significantly reduced in the δ-tocopherol and soybean lecithin combination group.

以上の結果から、δ−トコフェロール0,25%と大豆
レシチン0.25%の併用、添加は、δ−トコフェロー
ル0.5%単独添加に比べてδ−トコフェロールの添加
量が怖であるにもかかわらず、顕著な血中コレステロー
ルの低下効果を奏することが認められ比。
From the above results, the combination and addition of 0.25% δ-tocopherol and 0.25% soybean lecithin is more effective than adding 0.5% δ-tocopherol alone, even though the amount of δ-tocopherol added is scary. It has been found to have a significant effect on lowering blood cholesterol.

次に本発明の実施例を示す。Next, examples of the present invention will be shown.

実施例1゜ δ−ト′37エローに濃縮物(エーザイ甑製、イーミッ
クスD、δ−トコフェロール含t 94.8重量%)2
0重量部、大豆レシチン3[]lti部を小麦胚芽油5
0重量部に混合し、約60℃に加温、攪拌して均一に溶
解し良。
Example 1 δ-tocopherol concentrate (manufactured by Eisai Koshiki, Emix D, δ-tocopherol content: 94.8% by weight) 2
0 parts by weight, 3[]lti parts of soybean lecithin, 5 parts of wheat germ oil
0 parts by weight, heated to about 60°C and stirred to dissolve uniformly.

一方、ゼラチン60重量部、グリセリン30重量部、水
10重量部を均一に混合し、フィルム状にした後、容量
的300mFのカプセル状に射出成型してゼラチン等器
を製造した。
Separately, 60 parts by weight of gelatin, 30 parts by weight of glycerin, and 10 parts by weight of water were uniformly mixed, formed into a film, and then injection molded into a capsule having a capacitance of 300 mF to produce a gelatin container.

この容器に前記の混合液状物を注入し、しかる後、注入
口を加熱密刺して本発明の栄養補助食品を得た。
The above-mentioned liquid mixture was poured into this container, and then the injection port was heated and sealed to obtain the nutritional supplement of the present invention.

Claims (1)

【特許請求の範囲】[Claims] (1) δ−トコフエロールマタハδ−):=+7x。 −ルの組成比を50%以上に高めた混合トコフェロール
と大豆レシチンを液状植物油に溶解してなる混合液状物
をゼラチンのカプセル内に刺入した栄養補助食品。
(1) δ-tocopherolmataha δ-):=+7x. A nutritional supplement in which a liquid mixture obtained by dissolving mixed tocopherol and soybean lecithin in a liquid vegetable oil in which the composition ratio of tocopherol is increased to 50% or more is inserted into a gelatin capsule.
JP59070529A 1984-04-09 1984-04-09 Nutritious supplementary food Pending JPS60214864A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59070529A JPS60214864A (en) 1984-04-09 1984-04-09 Nutritious supplementary food

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59070529A JPS60214864A (en) 1984-04-09 1984-04-09 Nutritious supplementary food

Publications (1)

Publication Number Publication Date
JPS60214864A true JPS60214864A (en) 1985-10-28

Family

ID=13434147

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59070529A Pending JPS60214864A (en) 1984-04-09 1984-04-09 Nutritious supplementary food

Country Status (1)

Country Link
JP (1) JPS60214864A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231090A (en) * 1990-07-30 1993-07-27 University Of Miami Treatment for hypercholesterolemia
JPH08173035A (en) * 1994-12-22 1996-07-09 Kao Corp Stabilized tocopherol-containing oil and fat composition
WO2002034072A3 (en) * 2000-10-24 2002-10-10 Novartis Nutrition Ag Synergistic antioxidant combination of delta tocols and polyphenols

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231090A (en) * 1990-07-30 1993-07-27 University Of Miami Treatment for hypercholesterolemia
JPH08173035A (en) * 1994-12-22 1996-07-09 Kao Corp Stabilized tocopherol-containing oil and fat composition
WO2002034072A3 (en) * 2000-10-24 2002-10-10 Novartis Nutrition Ag Synergistic antioxidant combination of delta tocols and polyphenols
US7452549B2 (en) 2000-10-24 2008-11-18 Nestec S.A. Synergistic antioxidant combination of delta tocols and polyphenols

Similar Documents

Publication Publication Date Title
US6159507A (en) Food composition containing an omega-6/omega-3 unsaturated fatty acid balance modifier
US7179491B1 (en) Process of converting rendered triglyceride oil from marine sources into bland, stable oil
Ramadan et al. Coriander (Coriandrum sativum L.) seed oil improves plasma lipid profile in rats fed a diet containing cholesterol
CA2644152C (en) Soybean-germ oil and method for the production of germ-enriched soybean material
US4218489A (en) Antioxidants, antioxidant compositions and methods of preparing and using same
JP2013100506A (en) Special palm oil product and other special vegetable oil products
EP0519673B1 (en) Composition containing dioxabicyclo[3.3.0]octane derivative
ES2260333T3 (en) PROCEDURE FOR THE PRODUCTION OF TOCOTRIENOLES.
EP0729753B1 (en) Use of dioxabicyclo[3.3.0]actanes for treatment and prevention of cerebral apoplexy
AU2003232432A1 (en) Policosanol compositions, extraction from novel sources, and uses thereof
JPS60153779A (en) Nutrient-assisting food
Desai et al. Vitamin E content of crude and refined vegetable oils in Southern Brazil
JPS60197621A (en) Hypocholesterolemic
JPS60214864A (en) Nutritious supplementary food
JP3977889B2 (en) Drugs containing buckwheat husk extract as an active ingredient
KR20040101694A (en) A food containing -renolenic acid for a climacteric woman
JP2009096757A (en) Fat metabolism suppressing agent
EP1046341A1 (en) Food composition with a high polyunsaturated fatty acid content, its preparations and use in a proper alimentary diet
JPS57206336A (en) Edible oil
EP0743355A1 (en) Co-pressing of oilseeds
JPH0469614B2 (en)
CN115315198A (en) Composition for improving friendliness and/or co-emotion
JPS60153774A (en) Nutritive auxiliary food
JP2003304814A (en) Composition with high phosphatidyl serine content
CA2346407C (en) Process of converting rendered triglyceride oil from marine sources into bland, stable oil